| GENMAB AS DK 1 | 275.2000 / -3.47% |
| Date/Time | 03/03 / 10:45 |
| Chg. / Chg.(%) | -9.9000 / -3.47% |
| Bid | 272.5000 / 200 |
| Ask | 272.8000 / 200 |
| Open | 276.8000 |
| Previous Close | 285.1000 |
| High | 276.8000 |
| Low | 275.2000 |
| Volume [EUR] | 3,317.8000 |
| Volume [Units] | 12 |
| Price fixings | 4 |
| ISIN | DK0010272202 |
| Security | GE9 |
| Exchange | Frankfurt |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Cboe Europe .. | 2,028.00 |  |
27,744 |
| Turquoise | 2,028.00 | |
7,448 |
| London Inter.. | 2,036.0 | |
3,066 |
| Cboe Europe .. | 2,028.50 | |
170 |
| TradeGate | 272.700 | |
85 |
| Cboe Europe .. | 2,045.00 | |
65 |
| Frankfurt | 275.2000 | |
12 |
| gettex | 272.600 | |
3 |
| Vienna Globa.. | 278.20 | |
0 |
| München | 284.70 | |
0 |
| Düsseldorf | 273.50 | |
0 |
| Berlin | 274.00 | |
0 |
| Lang & Schwa.. | 272.30 | |
|
| Stuttgart | 274.800 | |
|
| OMX Nordic | 2,102.00 | |
189,102 |
| Nasdaq Other.. | 338.2800 | |
372 |
| Mexico | 7,638.15 | |
11,330 |
News
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02/25/2021 / 20:53 - GlobeNewswire - Genmab announces initiation of share buy-back program
02/23/2021 / 17:05 - GlobeNewswire - Genmab Publishes 2020 Annual Report
02/23/2021 / 17:00 - GlobeNewswire - Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
02/22/2021 / 14:00 - GlobeNewswire - Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
02/10/2021 / 22:05 - GlobeNewswire
Real-time